Germline variants of <em>IGHV3-53 / V3-66</em> are determinants of antibody responses to the BNT162b2 mRNA COVID-19 vaccine
Publication date: Available online 2 November 2022Source: Journal of InfectionAuthor(s): Yoichi Mashimo, Keiko Yamazaki, Takahiro Kageyama, Shigeru Tanaka, Toshibumi Taniguchi, Kazuyuki Matsushita, Hidetoshi Igari, Hideki Hanaoka, Koutaro Yokote, Hiros…